CD8A and myeloid sarcoma: While the specific autoantigens involved in MS pathogenesis remain unclear, evidence suggests that CD4+ and CD8+ T cells mediate autoimmune responses against CNS myelin antigens, particularly involving Th1 and Th17 CD8+ myelin-reactive T cells [186].